Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Virulence
|
March 11, 2017
Self-defense against Bacillus anthracis toxins: Is P-selectin the key?
John D Campbell
Methods in Molecular Biology (Clifton, N.J.)
|
October 9, 2016
Development of the CpG Adjuvant 1018: A Case Study
John D Campbell
NPJ Vaccines
|
July 22, 2022
A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice
Shirin Strohmeier, Fatima Amanat, John D Campbell, et al.
International Immunopharmacology
|
December 4, 2018
Preclinical development of the TLR9 agonist DV281 as an inhaled aerosolized immunotherapeutic for lung cancer: Pharmacological profile in mice, non-human primates, and human primary cells
Sariah A Kell, Melissa A Kachura, Alex Renn, et al.
Human Immunology
|
December 26, 2009
Isolation and characterization of human interleukin-10-secreting T cells from peripheral blood
Graziella Mazza, Catherine A Sabatos-Peyton, Rachel E Protheroe, et al.
Bioconjugate Chemistry
|
April 14, 2016
Optimization, Production, and Characterization of a CpG-Oligonucleotide-Ficoll Conjugate Nanoparticle Adjuvant for Enhanced Immunogenicity of Anthrax Protective Antigen
Bob Milley, Radwan Kiwan, Gary S Ott, et al.
American Journal of Physiology. Renal Physiology
|
February 25, 2005
Selective permeability barrier to urea in shark rectal gland
Joshua D Zeidel, John C Mathai, John D Campbell, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA
|
January 24, 2021
ACL Study Group survey reveals the evolution of anterior cruciate ligament reconstruction graft choice over the past three decades
Markus P Arnold, Jacob G Calcei, Nicole Vogel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 15, 2003
The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs
Robert Jan Veldman, Alain Mita, Olivier Cuvillier, et al.
Vaccine
|
September 3, 2024
Phase 1 trial of an investigational Tdap booster vaccine with CpG 1018 adjuvant compared with Boostrix in healthy adults and adolescents
Peter Richmond, Terry Nolan, Anthony McGirr, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Virulence
|
March 11, 2017
Self-defense against Bacillus anthracis toxins: Is P-selectin the key?
John D Campbell
Methods in Molecular Biology (Clifton, N.J.)
|
October 9, 2016
Development of the CpG Adjuvant 1018: A Case Study
John D Campbell
NPJ Vaccines
|
July 22, 2022
A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice
Shirin Strohmeier, Fatima Amanat, John D Campbell, et al.
International Immunopharmacology
|
December 4, 2018
Preclinical development of the TLR9 agonist DV281 as an inhaled aerosolized immunotherapeutic for lung cancer: Pharmacological profile in mice, non-human primates, and human primary cells
Sariah A Kell, Melissa A Kachura, Alex Renn, et al.
Human Immunology
|
December 26, 2009
Isolation and characterization of human interleukin-10-secreting T cells from peripheral blood
Graziella Mazza, Catherine A Sabatos-Peyton, Rachel E Protheroe, et al.
Bioconjugate Chemistry
|
April 14, 2016
Optimization, Production, and Characterization of a CpG-Oligonucleotide-Ficoll Conjugate Nanoparticle Adjuvant for Enhanced Immunogenicity of Anthrax Protective Antigen
Bob Milley, Radwan Kiwan, Gary S Ott, et al.
American Journal of Physiology. Renal Physiology
|
February 25, 2005
Selective permeability barrier to urea in shark rectal gland
Joshua D Zeidel, John C Mathai, John D Campbell, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA
|
January 24, 2021
ACL Study Group survey reveals the evolution of anterior cruciate ligament reconstruction graft choice over the past three decades
Markus P Arnold, Jacob G Calcei, Nicole Vogel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 15, 2003
The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs
Robert Jan Veldman, Alain Mita, Olivier Cuvillier, et al.
Vaccine
|
September 3, 2024
Phase 1 trial of an investigational Tdap booster vaccine with CpG 1018 adjuvant compared with Boostrix in healthy adults and adolescents
Peter Richmond, Terry Nolan, Anthony McGirr, et al.
Page
of 4